People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

11:15am EDT
Change (% chg)

103.50p (+2.58%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Dunoyer, Marc 

Mr. Marc Dunoyer has been appointed as Chief Financial Officer, Executive Director of AstraZeneca PLC, effective 1 November 2013. He joined AstraZeneca from GlaxoSmithKline in June 2013. Marc qualified as an accountant. His subsequent career in pharmaceuticals has given him extensive experience of the industry including finance and accounting; corporate strategy and planning; research and development; sales and marketing; business reorganisation; and business development. A French national with a background in finance and accounting, Marc Dunoyer began his career in the pharmaceutical industry at Roussel Uclaf in Paris in the 1970s before being promoted to the position of President, Japan and then President, Asia Pacific. After returning to France for a period as Managing Director, Global Pharmaceuticals Division, Roussel Uclaf in the 1990s, Marc was appointed President & CEO, Asia Pacific & Japan for Hoechst Marion Roussel in 1995. In 2000, he was recruited by Glaxo Wellcome - just ahead of the merger that created GlaxoSmithKline - as Regional President, Japan and subsequently Regional President, Asia Pacific & Japan. His most recent role before joining AstraZeneca was Global Head of Rare Diseases and (concurrently) Chairman, GSK Japan for GlaxoSmithKline. Marc has an MBA from the Hautes Etudes Commerciales and has a Bachelor of Law degree from Paris University. He qualified as a Junior Certified Public Accountant in France.

Basic Compensation

Total Annual Compensation, GBP 259,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 37,000
Fiscal Year Total, GBP 296,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson


Pascal Soriot


Marc Dunoyer


Ruud Dobber


Caroline Hempstead


Paul Hudson

As Of  30 Dec 2013
Search Stocks